Shares of cannabis operators, including Tilray, surged following reports that the administration is preparing to reclassify the substance. The move aims to expand medical research and facilitate access to traditional banking services for the industry.
- Cannabis stocks surged on reclassification reports
- Potential for expanded medical research
- Expected improvement in banking access for growers
- Action aligns with a December executive order
- Reduced operational risk for sector participants
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.